Precision Medicine Beyond Oncology

11:00 AM - 12:00 PM, Wednesday, June 5,2019 ・ 116, Level 100
Precision Medicine has helped transform cancer care from one-size-fits-all chemotherapy to a new era, where patients’ tumors can be analyzed and therapy selected based on their genetic makeup. Until now, however, precision medicine’s impact has been far less in other therapeutic areas, many of which are ripe for transformation. Efforts are underway to bring the successes of precision medicine to neurology, immunology, ophthalmology, and other areas. This move raises key questions of how the lessons learned in oncology can be used to advance precision medicine in other fields, what types of data and tools will be important to personalizing treatment in these areas, and what sorts of partnerships and payer initiatives will be needed to support these approaches and their ultimate commercialization and use. The panel will also provide an in depth look at precision medicine approaches aimed at better understanding and improving patient care in highly complex disease areas like neurology.
Speakers
photo
Executive Vice President and Chief Medical and Technology Officer
Cepheid
photo
Global Personalised Healthcare Lead, Specialty Care
Roche
photo
Precision Medicine Practice Lead
Bionest Partners